NSE · AI Signal & Stock Analysis · Bearish
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for GLENMARK is Bearish ↓ (mild move); technical trend raise-2026-08-20; trading at ₹2,451.90 (+0.60% today); neutral (RSI 62).
Data as of Sep 28 2026, 6:47 PM. Informational analytics only — not investment advice.
| AI signal | Bearish ↓ · Mild move |
|---|---|
| Technical trend | RAISE-2026-08-20 |
| Price | ₹2,451.90 |
| Change today | +0.60% |
| RSI (14) | 62.30 |
| Relative volume | 0.44 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹65,637 Cr |
| P/E | 36.46 |
| Cap category | Large Cap |
| 52-week high | -2.4% away |
| 52-week low | +35.4% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for GLENMARK (Glenmark Pharmaceuticals Limited) is Bearish with a mild move, and its technical trend is raise-2026-08-20. The composite score and full factor breakdown are available to signed-in members.
GLENMARK's RSI is neutral (RSI 62). A reading above 70 is typically overbought and below 30 oversold.
GLENMARK is trading about 2% below its 52-week high and 35% above its 52-week low as of Sep 28 2026, 6:47 PM.
GLENMARK's market capitalisation is ₹65,637 Cr as of Sep 28 2026, 6:47 PM.
GLENMARK is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for GLENMARK — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 28 2026, 6:47 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.